• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1990年至2021年中国早发癌症疾病负担趋势:基于2021年全球疾病负担研究的系统分析

Trends in the disease burden of early-onset cancers in China from 1990 to 2021: a systematic analysis of the 2021 Global Burden of Disease study.

作者信息

Zhu Jicun, Li Tiandong, Chen Jiajun, Xue Wenhua, Liang Shuhong, Xie Chen, Han Xiting, Hao Weiwei, He Yixin, Qiao Gaoxing, Duan Xiaoran, Li Lifeng, Zhao Jie

机构信息

National Engineering Laboratory for Internet Medical Systems and Applications, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, P. R. China.

Department of Pharmacy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, P. R. China.

出版信息

BMC Cancer. 2025 Jul 12;25(1):1168. doi: 10.1186/s12885-025-14578-y.

DOI:10.1186/s12885-025-14578-y
PMID:40652211
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12256004/
Abstract

BACKGROUND

In recent years, the incidence of early-onset cancers among individuals under 50 years of age has been on the rise. We aimed to analyze the disease burden and temporal trends of early-onset cancers in China, providing a basis for policymakers to develop appropriate strategies.

METHODS

We utilized data from the 2021 Global Burden of Disease (GBD) study to describe the changes in early-onset cancers in China from 1990 to 2021, including incidence, mortality and disability-adjusted life years (DALYs). The age-standardized average annual percentage change (AAPC) was estimated using the Joinpoint regression program.

RESULTS

From 1990 to 2021, the incidence rate of all early-onset cancers in China increased by 150.72 per 100,000, while the mortality and DALY rates decreased by 4.30 per 100,000 and 279.34 per 100,000, respectively. In 2021, early-onset breast cancer had the highest incidence rate (17.14 per 100,000), and trachea/bronchus/lung cancer had the highest mortality rate (6.15 per 100,000) and DALY rate (292.48 per 100,000). The standardized DALY rate of all early-onset cancers decreased (AAPC = -1.49%, 95% CI: -1.51% to -1.46%), while multiple myeloma, neuroblastoma and other peripheral nervous cell tumors, malignant neoplasm of bone and articular cartilage, kidney cancer, and mesothelioma showed significant increases with AAPC of 4.14% (4.01-4.28%), 3.83% (3.77-3.88%), 1.20% (1.16-1.25%), 0.65% (0.58-0.73%), and 0.33% (0.29-0.37%), respectively. Tobacco consumption (23.01%) was the primary contributor to the disease burden of early-onset cancers in males, whereas unsafe sexual behavior (10.53%) was the primary contributor in females.

CONCLUSION

The mortality and DALY rate of early-onset cancers in China decreased, while the incidence rate increased. Trachea/bronchus/lung cancer is one of the most severe early-onset cancers, and effective measures need to be taken against the main risk factors.

摘要

背景

近年来,50岁以下个体中早发性癌症的发病率呈上升趋势。我们旨在分析中国早发性癌症的疾病负担和时间趋势,为政策制定者制定适当策略提供依据。

方法

我们利用2021年全球疾病负担(GBD)研究的数据来描述1990年至2021年中国早发性癌症的变化,包括发病率、死亡率和伤残调整生命年(DALYs)。使用Joinpoint回归程序估计年龄标准化平均年度百分比变化(AAPC)。

结果

1990年至2021年,中国所有早发性癌症的发病率每10万人增加150.72例,而死亡率和DALY率分别每10万人下降4.30例和279.34例。2021年,早发性乳腺癌的发病率最高(每10万人17.14例),气管/支气管/肺癌的死亡率最高(每10万人6.15例)和DALY率最高(每10万人292.48例)。所有早发性癌症的标准化DALY率下降(AAPC = -1.49%,95%CI:-1.51%至-1.46%),而多发性骨髓瘤、神经母细胞瘤和其他周围神经细胞瘤、骨和关节软骨恶性肿瘤、肾癌和间皮瘤则显著增加,AAPC分别为4.14%(4.01-4.28%)、3.83%(3.77-3.88%)、1.20%(1.16-1.25%)、0.65%(0.58-0.73%)和0.33%(0.29-0.37%)。烟草消费(23.01%)是男性早发性癌症疾病负担的主要贡献因素,而不安全的性行为(10.53%)是女性的主要贡献因素。

结论

中国早发性癌症的死亡率和DALY率下降,而发病率上升。气管/支气管/肺癌是最严重的早发性癌症之一,需要针对主要危险因素采取有效措施。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa08/12256004/13054f680639/12885_2025_14578_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa08/12256004/8037cc159a48/12885_2025_14578_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa08/12256004/13054f680639/12885_2025_14578_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa08/12256004/8037cc159a48/12885_2025_14578_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa08/12256004/13054f680639/12885_2025_14578_Fig2_HTML.jpg

相似文献

1
Trends in the disease burden of early-onset cancers in China from 1990 to 2021: a systematic analysis of the 2021 Global Burden of Disease study.1990年至2021年中国早发癌症疾病负担趋势:基于2021年全球疾病负担研究的系统分析
BMC Cancer. 2025 Jul 12;25(1):1168. doi: 10.1186/s12885-025-14578-y.
2
Global trends in testicular and prostate cancer among adolescents and young adult males aged 15-49 years, 1990-2021: insights from the GBD study.1990年至2021年15至49岁青少年及青年男性睾丸癌和前列腺癌的全球趋势:来自全球疾病负担研究的见解
Sci Rep. 2025 Jul 2;15(1):23388. doi: 10.1038/s41598-025-07361-3.
3
Burden of knee osteoarthritis in China and globally: 1990-2045.中国及全球膝关节骨关节炎负担:1990 - 2045年
BMC Musculoskelet Disord. 2025 Jul 1;26(1):582. doi: 10.1186/s12891-025-08858-8.
4
Incidence and disability-adjusted life-years of infective endocarditis in China from 1990 to 2021: comparison with G20 based on the Global Burden of Disease Study 2021.1990年至2021年中国感染性心内膜炎的发病率和伤残调整生命年:基于《2021年全球疾病负担研究》与二十国集团的比较
BMJ Open. 2025 Jul 6;15(7):e094490. doi: 10.1136/bmjopen-2024-094490.
5
Hepatoblastoma regional trends: dynamic SDI & joinpoint regression analysis.肝母细胞瘤的区域趋势:动态社会人口指数与连接点回归分析
BMC Cancer. 2025 Jul 5;25(1):1148. doi: 10.1186/s12885-025-14566-2.
6
Burden of hematologic malignancies in China from 1990 to 2021: analysis from the Global Burden of Disease Study 2021.1990年至2021年中国血液系统恶性肿瘤负担:来自《2021年全球疾病负担研究》的分析
BMC Public Health. 2025 Jul 2;25(1):2280. doi: 10.1186/s12889-025-23469-7.
7
The burden of low back pain in BRICS: an analysis for the global burden of disease study 2021.金砖国家中腰痛的负担:2021年全球疾病负担研究分析
Front Public Health. 2025 Jun 30;13:1563260. doi: 10.3389/fpubh.2025.1563260. eCollection 2025.
8
[Disease burden of spinal fractures in China from 1990 to 2021 and temporal trends: A comparative analysis based on the Global Burden of Disease Study 2021].1990年至2021年中国脊柱骨折的疾病负担及时间趋势:基于《2021年全球疾病负担研究》的比较分析
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2025 Jun 15;39(6):762-768. doi: 10.7507/1002-1892.202504088.
9
[Disease burden and future trend predictions of age-related hearing loss in China and worldwide from 1990 to 2021].[1990年至2021年中国及全球年龄相关性听力损失的疾病负担及未来趋势预测]
Beijing Da Xue Xue Bao Yi Xue Ban. 2025 Jun 18;57(3):545-553. doi: 10.19723/j.issn.1671-167X.2025.03.019.
10
Burden of kidney cancer in China from 1990 to 2021 and predictions for 2036: an age-period-cohort analysis of global burden of disease study 2021.1990年至2021年中国肾癌负担及2036年预测:全球疾病负担研究2021的年龄-时期-队列分析
BMC Public Health. 2025 Jul 2;25(1):2211. doi: 10.1186/s12889-025-23476-8.

本文引用的文献

1
Rising Incidence and Mortality of Early-Onset Colorectal Cancer in Young Cohorts Associated with Delayed Diagnosis.年轻人群中早发性结直肠癌的发病率和死亡率上升与诊断延迟有关。
Cancers (Basel). 2025 Apr 29;17(9):1500. doi: 10.3390/cancers17091500.
2
Global trends in incidence, death, burden and risk factors of early-onset cancer from 1990 to 2019.1990年至2019年早发性癌症的发病率、死亡率、疾病负担及风险因素的全球趋势。
BMJ Oncol. 2023 Sep 5;2(1):e000049. doi: 10.1136/bmjonc-2023-000049. eCollection 2023.
3
Trends in incidence and mortality of early-onset cancer in Germany between 1999 and 2019.
1999 年至 2019 年德国早发性癌症发病和死亡趋势。
Eur J Epidemiol. 2024 Jul;39(7):827-837. doi: 10.1007/s10654-024-01134-4. Epub 2024 May 31.
4
Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study 2021.204 个国家和地区 2022-2050 年疾病负担情景:2021 年全球疾病负担研究的预测分析。
Lancet. 2024 May 18;403(10440):2204-2256. doi: 10.1016/S0140-6736(24)00685-8.
5
Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.全球疾病负担研究 2021 年在 204 个国家和地区、811 个次国家级地点对 88 种风险因素的全球负担和证据强度:系统分析。
Lancet. 2024 May 18;403(10440):2162-2203. doi: 10.1016/S0140-6736(24)00933-4.
6
Esophageal cancer screening, early detection and treatment: Current insights and future directions.食管癌筛查、早期检测与治疗:当前见解与未来方向。
World J Gastrointest Oncol. 2024 Apr 15;16(4):1180-1191. doi: 10.4251/wjgo.v16.i4.1180.
7
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.全球疾病、伤害和危险因素负担研究 2021 年,1990-2021 年全球 204 个国家和地区及 811 个次国家地区 371 种疾病和伤害的发病率、患病率、伤残损失生命年(YLDs)、伤残调整生命年(DALYs)以及健康期望寿命(HALE):系统分析
Lancet. 2024 May 18;403(10440):2133-2161. doi: 10.1016/S0140-6736(24)00757-8. Epub 2024 Apr 17.
8
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.2022 年全球癌症统计数据:全球 185 个国家和地区 36 种癌症的发病率和死亡率全球估计数。
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.
9
Comprehensive approach to controlling chronic hepatitis B in China.中国慢性乙型肝炎防治指南
Clin Mol Hepatol. 2024 Apr;30(2):135-143. doi: 10.3350/cmh.2023.0412. Epub 2024 Jan 5.
10
Cancer profiles in China and comparisons with the USA: a comprehensive analysis in the incidence, mortality, survival, staging, and attribution to risk factors.中国癌症概况及与美国的比较:发病率、死亡率、生存率、分期和归因于危险因素的综合分析。
Sci China Life Sci. 2024 Jan;67(1):122-131. doi: 10.1007/s11427-023-2423-1. Epub 2023 Sep 21.